REGINfo: GALAPAGOS - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- Energean Oil Gas
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- LivePerson
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

COMPANY SEARCH RESULT

$GALAPAGOS: Click to view the issuer\'s details$

Last update : 21/08/2018 >View issuer details

2021.05.06 | 22:01 | Permanent Information Releases / General Company News

puce Galapagos refocuses pipeline and rightsizes operations - HTML (w)

2021.05.06 | 22:01 | Permanent Information Releases / General Company News

puce Galapagos heroriënteert pijplijn en stroomlijnt organisatie - HTML (w)

2021.05.04 | 22:01 | Permanent Information Releases / General Company News

puce Transparency notification received from The Capital Group - HTML (w)

2021.05.04 | 22:01 | Permanent Information Releases / General Company News

puce Transparantieverklaring ontvangen van The Capital Group - HTML (w)

2021.04.30 | 22:01 | Permanent Information Releases / General Company News

puce Galapagos creates new subscription right plans - HTML (w)

2021.04.30 | 22:01 | Permanent Information Releases / General Company News

puce Galapagos creëert nieuwe inschrijvingsrechtenplannen - HTML (w)

2021.04.23 | 06:01 | Permanent Information Releases / General Company News

puce Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies - HTML (w)

2021.04.23 | 06:01 | Permanent Information Releases / General Company News

puce Gilead Sciences dient goedkeuringsaanvraag in Japan in voor filgotinib voor de behandeling van colitis ulcerosa bij patiënten met onvoldoende respons op conventionele behandelingen - HTML (w)

2021.04.08 | 22:01 | Permanent Information Releases / General Company News

puce Extension of lock-up period in Gilead-Galapagos collaboration agreement - HTML (w)

2021.04.08 | 22:01 | Permanent Information Releases / General Company News

puce Verlenging van de lock-up-periode in samenwerkingsovereenkomst tussen Gilead & Galapagos - HTML (w)

2021.03.25 | 21:01 | Permanent Information Releases / General Company News

puce Publication of the annual report and invitation to the ordinary shareholders’ meeting - HTML (w)

2021.03.25 | 21:01 | Permanent Information Releases / General Company News

puce Publicatie van het jaarverslag en uitnodiging voor de gewone algemene vergadering - HTML (w)

2021.03.24 | 21:01 | Permanent Information Releases / General Company News

puce Galapagos benoemt Bart Filius tot President en Chief Operating Officer - HTML (w)

2021.03.24 | 21:01 | Permanent Information Releases / Appointments

puce Galapagos appoints Bart Filius as President and Chief Operating Officer - HTML (w)

2021.03.19 | 22:01 | Permanent Information Releases / General Company News

puce Galapagos increases share capital through subscription right exercises - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 324